IAVI, CureVac team up to accelerate AIDS vaccine development; GeoVax Ebola jab reports 100% protection in animal study;

> The International AIDS Vaccine Initiative (IAVI) is partnering with CureVac to accelerate the development of AIDS vaccines. Release

> GeoVax's Ebola vaccine posts 100% protection in guinea pigs and Syrian golden hamsters. More

> Walvax Biotechnology is using Medidata's ($MDSO) cloud-based platform to advance the development of a pediatric pneumococcal vaccine in China. Release

> Researchers at VIB and Ghent University in Belgium found a link between exposure to "farm dust" and protection against asthma and allergies. Release

Suggested Articles

Already developing coronavirus treatments, Takeda struck a licensing deal to manufacture and market Novavax's vaccine candidate in Japan

On the heels of last week's deal for 120 million Pfizer-BioNTech shots, Japan has locked down 120 million more vaccines from AstraZeneca.

The pandemic price could be lowered for larger deals, CEO Stephane Bancel said. Pfizer and BioNTech priced 100M doses at $19.50 each for the U.S.